A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates.

Published in:

FASEB Journal, 2012, v. 26, n. 5, p. 2154, doi. 10.1096/fj.11-195016

By:

• Johnston, Tom H.;
• Millar, Zak;
• Huot, Philippe;
• Wagg, Keith;
• Thiele, Sherri;
• Salomonczyk, Danielle;
• Yong-Kee, Christopher J.;
• Gandy, Michael N.;
• McIldowie, Matthew;
• Lewis, Katie D.;
• Gomez-Ramirez, Jordi;
• Joohyung Lee;
• Fox, Susan H.;
• Martin-Iverson, Mathew;
• Nash, Joanne E.;
• Piggott, Matthew J.;
• Brotchie, Jonathan M.

Publication type:

Article